FACIT and Triphase Accelerator Announce New Partnership with Celgene for First-in-class WDR5 Leukemia Therapy Read more
Join experts within Pharmaceuticals and Life sciences in just one week at Europe’s Only Parallel Trade Conference 2019 in London Read more
Horizon Discovery and Rutgers University form exclusive partnership to develop next generation novel gene editing technology Read more
An interview with Heiko Goette, Biostatistician, Merck ahead of Adaptive Designs in Clinical Trials just released Read more
Concert Pharma Initiates Phase 1 Single-Ascending Dose Trial of CTP-692 as an Adjunctive Treatment for Schizophrenia Read more